RxSight Inc. witnessed a dramatic 34% drop in after-hours trading after announcing revisions to its 2025 revenue forecast, sparking concerns among investors. The company’s stock closed at $8.40, down from $12.79, highlighting the market’s reaction to the updated financial outlook.

A new report from Harvard University’s Joint Center for Housing Studies reveals growing uncertainty in the U.S. housing market. Managing Director Chris Herbert discusses what this means for homeowners and buyers.

Global investors are finding it increasingly difficult to navigate markets roiled by erratic U.S. trade rhetoric and chaotic economic forecasting. Making long-term investment decisions has become a significant challenge.